A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia.

Saved in:
Bibliographic Details
Title: A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia.
Authors: Najarian D; Janssen Scientific Affairs, LLC, New Jersey, USA., Sanga P; Janssen Research and Development LLC, New Jersey, USA., Wang S; Janssen Research and Development LLC, New Jersey, USA., Lim P; Janssen Research and Development LLC, New Jersey, USA., Singh A; Janssen Research and Development LLC, New Jersey, USA., Robertson MJ; Janssen Research and Development LLC, New Jersey, USA., Cohen K; Janssen Research and Development LLC, New Jersey, USA., Schotte A; Janssen Research and Development, Beerse, Belgium., Milz R; Janssen-Cilag, Neuss, Germany., Venkatasubramanian R; Janssen Research and Development LLC, New Jersey, USA., T'Jollyn H; Janssen Research and Development, Beerse, Belgium., Walling DP; CNS Network, LLC, Garden Grove, California, USA., Galderisi S; University of Campania 'Luigi Vanvitelli,' Naples, Italy., Gopal S; Janssen Research and Development LLC, New Jersey, USA.
Source: The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2022 Mar 17; Vol. 25 (3), pp. 238-251.
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Equivalence Trial
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9815893 Publication Model: Print Cited Medium: Internet ISSN: 1469-5111 (Electronic) Linking ISSN: 14611457 NLM ISO Abbreviation: Int J Neuropsychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1469-5111
DOI:10.1093/ijnp/pyab071